Eli Lilly & Co announced a bond offering on August 18, 2025, raising approximately $6.71 billion from the sale of various notes with maturities ranging from 2028 to 2065. The issuance includes $750 million of Floating Rate Notes due 2028 and $1 billion of 4.550% Notes due 2032, among others.